Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: WHO
The elephant in the room at the WHO Executive Board
Ellen 't Hoen
-
January 22, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
Human Rights Watch: All governments should endorse the WHO C-TAP Solidarity...
Kaitlin Mara
-
October 30, 2020
WTO Members discuss proposal to suspend certain intellectual property protection during...
Ellen 't Hoen
-
October 14, 2020
Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to...
Medicines Law & Policy
-
May 29, 2020
Invitation: 14 May 2020 – The WHO Covid-19 Technology Pool: The...
Kaitlin Mara
-
May 12, 2020
The € 7.4 billion for Covid-19 product and vaccine development needs...
Ellen 't Hoen
-
May 5, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
Urgent collective action to meet the challenge of this pandemic crisis:...
Christopher Garrison
-
March 30, 2020
Wrapping up 2019 – Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 30, 2019
1
2
Page 1 of 2
This work is licensed under Creative Commons.